Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Kidney Neoplasms × talazoparib × Clear all

Sponsor

Conditions

Breast Neoplasms 12 Triple Negative Breast Neoplasms 5 Advanced Solid Tumors 4 Prostatic Neoplasms 3 Ovarian Neoplasms 3 Pancreatic Neoplasms 2 Neoplasms 2 Fallopian Tube Neoplasms 2 Colorectal Neoplasms 2 Carcinoma, Ovarian Epithelial 2 mCRPC 1 Squamous Cell Carcinoma of Head and Neck 1 Solid Tumor 1 Small Cell Lung Carcinoma 1 Sarcoma, Ewing 1 Recurrent Squamous Cell Lung Carcinoma 1 Recurrence 1 Neuroectodermal Tumors, Primitive, Peripheral 1 Neoplasm Metastasis 1 Leukemia, Myeloid, Acute 1 Hereditary Sensory and Autonomic Neuropathies 1 Fanconi Anemia, Complementation Group D1 1 Endometrial Neoplasms 1 Central Nervous System Neoplasms 1 Carcinoma, Renal Cell 1 Carcinoma, Non-Small-Cell Lung 1 Breast Adenocarcinoma 1 Advanced Solid Tumor 1 Advanced Ovarian Cancer 1 ATM Gene Mutation 1

Interventions

Sunitinib 16 Everolimus 15 Bevacizumab 12 aldesleukin 10 Sorafenib 10 Cyclophosphamide 10 Nivolumab 9 Interleukin-2 9 fludarabine phosphate 7 fludarabine 7 Axitinib 7 Gemcitabine 5 temsirolimus 4 pembrolizumab 4 pazopanib 4 Ipilimumab 4 peginterferon alfa-2b 3 durvalumab 3 Radiosurgery 3 Interferon-alpha 3 Filgrastim 3 Erlotinib Hydrochloride 3 Cryosurgery 3 vandetanib 2 perflutren 2 ixabepilone 2 chiron 2 carfilzomib 2 cabozantinib 2 belzutifan 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡